Novo Reports CagriSema Weight Loss and Function Results
Plainsboro, New Jersey, USA, and Bagsværd, Denmark, November 15, 2026 Novo Nordisk has announced two new post hoc analyses...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Plainsboro, New Jersey, USA, and Bagsværd, Denmark, November 15, 2026 Novo Nordisk has announced two new post hoc analyses...
Indianapolis, Indiana, USA, November 14, 2026 Eli Lilly and Company has announced a comprehensive set of new clinical trial...
Washington, D.C., USA, November 14, 2026 Novo Nordisk has announced positive primary results from its Phase 3 REDEFINE 9...
Boulder, Colorado, USA, November 15, 2026 Ambrosia Biosciences has announced new nonclinical findings for two investigational oral small-molecule drug...
Shanghai, China, November 11, 2026 Laekna Inc. has announced that its internally discovered investigational drug candidate LAE124, a novel...
New York, New York, U.S., and Cambridge, Massachusetts, U.S., November 11, 2026 Pfizer Inc. and Blackstone Life Sciences have...
Hong Kong, China, November 11, 2026 Ascletis Pharma Inc. has announced the submission of an Investigational New Drug (IND)...
Indianapolis, Indiana, United States, November 10, 2026 Eli Lilly and Company has announced the launch of a new patient-focused...
Ingelheim am Rhein, Germany, November 9, 2026 Boehringer Ingelheim has announced positive results from its global Phase III SYNCHRONIZE-CVOT...
Plainsboro, New Jersey, USA, and Bagsværd, Denmark, November 6, 2026 Novo Nordisk has announced new real-world clinical findings showing...
